Mitochondria-Targeted Biophysical Priming of Autologous Biologics for Skin Regeneration and Wound Repair
Geun-Ho Kang1,2, Kilyong Lee1,2, Chang Hwan Jeon1
1Spine Center, Seoul Yes Hospital, 2736, Yonggu-daero, Suji-gu, Yongin-si 16868, Gyeonggi-do, Republic of Korea.
Abstract:
Skin aging, photoaging, and chronic wounds are increasingly recognized to be driven by mitochondria-centered mechanisms characterized by oxidative stress, defective mitophagy, and impaired bioenergetics in cutaneous cells. Autologous biologics, including platelet-rich plasma, stromal vascular fraction, bone marrow aspirate concentrate, and mesenchymal stromal/stem cell-derived products, are widely used for skin rejuvenation and wound repair. Recent studies have suggested that many of these effects are mediated by mitochondrial mechanisms, including metabolic reprogramming, redox modulation, and intercellular mitochondrial transfer. Concurrently, biophysical modalities such as red/near-infrared photobiomodulation (PBM), low-intensity pulsed ultrasound, mechanical stimulation, and nanoengineered cues can modulate mitochondrial function in skin-relevant cells. In this review, we integrate these lines of evidence to introduce the concept of mitochondria-targeted biophysical priming of autologous biologics for dermatological applications. We summarize the mitochondrial biology in skin pathology, evaluate these biologics as mitochondria-active therapies, and outline ex vivo priming implementation using PBM, ultrasound, or mechanical stimulation. Finally, we discuss key regulatory considerations that support clinical translation.
Insights
Mitochondria-centered mechanisms drive skin aging and wounds. Biophysical priming of autologous biologics enhances skin repair by targeting these mitochondrial pathways.
Area of Science:
- Dermatology and Regenerative Medicine
- Mitochondrial Biology
- Biophysics
Background:
- Skin aging, photoaging, and chronic wounds involve mitochondrial dysfunction, including oxidative stress and impaired energy production.
- Autologous biologics are used for skin rejuvenation and wound healing, with emerging evidence linking their efficacy to mitochondrial effects.
- Biophysical modalities can directly modulate mitochondrial function in skin cells.
Purpose of the Study:
- To review the role of mitochondria in skin pathologies.
- To evaluate autologous biologics as mitochondria-active therapies.
- To introduce the concept of biophysical priming of autologous biologics for dermatological applications.
Main Methods:
- Literature review integrating mitochondrial biology, autologous biologics, and biophysical modalities.
- Evaluation of ex vivo priming strategies using photobiomodulation, ultrasound, and mechanical stimulation.
- Discussion of regulatory considerations for clinical translation.
Main Results:
- Mitochondrial dysfunction is central to skin aging and wound healing.
- Autologous biologics exert therapeutic effects partly through mitochondrial mechanisms.
- Biophysical methods can enhance the mitochondrial activity of autologous biologics.
Conclusions:
- Mitochondria-targeted biophysical priming represents a novel strategy for enhancing autologous biologic therapies in dermatology.
- This approach holds promise for improving outcomes in skin rejuvenation and chronic wound repair.
- Further research and regulatory guidance are needed for clinical implementation.
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
01:23Tissue Renewal without Stem Cells
However, failure of such a system...